NS5A-IN-1
NS5A-IN-1 is a proagent of the HCV NS5A inhibitor Pibrentasvir (ABT-530) .
Product Specifications
UNSPSC
12352005
Target
HCV Protease
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ns5a-in-1.html
Solubility
10 mM in DMSO
Smiles
COC(N[C@@H]([C@H](OC)C)C(N1CCC[C@H]1C2=NC3=CC(F)=C(C=C3N2)[C@H]4CC[C@@H](N4C5=CC(F)=C(C(F)=C5)N6CCC(CC6)C7=CC=C(C=C7)F)C8=CC9=C(N(C([C@@H]%10CCCN%10C([C@H]([C@H](OC)C)NC(OC)=O)=O)=N9)CCOC(CC(C)(C%11=C(C=C(C=C%11C)C)OP(O)(O)=O)C)=O)C=C8F)=O)=O
Molecular Formula
C72H86F5N10O14P
Molecular Weight
1441.48
References & Citations
[1]Randolph JT, et al. Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530) . J Med Chem. 2020 Oct 8;63 (19) :11034-11044.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog